September 2026
1. MANEESRIWONGUL W, Deesamer S, Butsing N
   Factors influencing Thai parents' COVID-19 vaccine acceptance for their children: Vaccine attitudes, beliefs, and children's past influenza vaccination.
   Virus Res. 2026 Sep 20:199805. doi: 10.1016/j.virusres.2026.199805.
   

   >> Share

   
   
2. ZHENG YT, Jin XZ, Zhang CJ, Chen SS, et al
   An IMS 1313-Based Inactivated PRV Vaccine with a novel immunopotentiator induces Robust Protective Immunity against Virulent Variants.
   Virus Res. 2026 Sep 14:199801. doi: 10.1016/j.virusres.2026.199801.
   

   >> Share

   
   August 2026
3. LEE JY, Choi JA, Jung DI, Park Y, et al
   An inactivated human adenovirus type 55 vaccine attenuates pulmonary pathology in a non-human primate challenge model.
   Virus Res. 2026 Aug 20:199793. doi: 10.1016/j.virusres.2026.199793.
   

   >> Share

   
   
4. LI X, Niu Z, Mou T, Gao Y, et al
   Expression and Immunogenicity of a Rabies Virus Glycoprotein-HSV-2 ICP35 Fusion Antigen Delivered by an mRNA-LNP Formulation.
   Virus Res. 2026 Aug 12:199785. doi: 10.1016/j.virusres.2026.199785.
   

   >> Share

   
   June 2026
5. STUART PM, Yin ZT
   Vaccination with an HSV-1 virus containing CD-137L reduces herpetic corneal disease when used both prophylactically and therapeutically.
   Virus Res. 2026 Jun 30:199773. doi: 10.1016/j.virusres.2026.199773.
   

   >> Share

   
   May 2026
6. SEDAGHAT M, Najafi F, Khosravi Shademani F, Rezaeian S, et al
   Seasonal influenza vaccine and frequency of adverse events in health workers receiving two doses of AstraZeneca vaccine: a retrospective cohort study.
   Virus Res. 2026;369:199757.
   

   >> Share

   
   
7. VALENZUELA-FUENZALIDA JJ, Velarezco LM, Silva V, Delgado F, et al
   Occurrence of Myocarditis in Patients Immunized with Different Types of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
   Virus Res. 2026 May 20:199748. doi: 10.1016/j.virusres.2026.199748.
   

   >> Share

   
   
8. AGGAD WS, Mishra SK, Alqahtani T, Guendouzi A, et al
   Epitope-based vaccine of NiV targeting glycoprotein and fusion protein: an integrated immunoinformatics and bioinformatics approach.
   Virus Res. 2026;369:199746.
   

   >> Share

   
   April 2026
9. LYU Y, Liu J, Qiao Y, Liu M, et al
   Development and Protective Evaluation of mRNA Vaccines Encoding the Glycoprotein Precursor of Lymphocytic Choriomeningitis Virus.
   Virus Res. 2026 Apr 26:199735. doi: 10.1016/j.virusres.2026.199735.
   

   >> Share

   
   
10. FARSIU N, Mahani FK, Arefinia N, Charostad J, et al
    From Legacy to Innovation: A Comprehensive Review of Vaccine Platforms Against Viral Infections.
    Virus Res. 2026 Apr 16:199730. doi: 10.1016/j.virusres.2026.199730.
    

    >> Share

    
    
11. XU M, Zhang C, Liu Y, Chen S, et al
    Corrigendum to"A noval strategy of deletion in PK gene for construction of a vaccine candidate with exellent safety and complete protection efficiency against high virulent Chinese pseudorabies virus variant" [Virus Research 313 (2022) 198740].
    Virus Res. 2026 Apr 8:199719. doi: 10.1016/j.virusres.2026.199719.
    

    >> Share

    
    
12. WU Y, Sun W, Xia Y, Feng Y, et al
    The influenza B virus candidate vaccine expressing H3 hemagglutinin developed in suspension MDCK cells confers protection against lethal H3N2 avian influenza in BALB/c mice.
    Virus Res. 2026;367:199722.
    

    >> Share

    
    
13. SITHOLE MN, Khan MR, Mohammed HA, Khan RA, et al
    A Systematic Review on Vaccine Developmental Approaches: Evaluating Efficacy, and Addressing Challenges of Infectious Diseases in the Post-COVID-19 Era.
    Virus Res. 2026 Apr 1:199720. doi: 10.1016/j.virusres.2026.199720.
    

    >> Share

    
    March 2026
14. YUNUS AO, Olanrewaju OA
    Fractional-order Modeling of Vaccination Strategies for Measles Transmission Incorporating Immune Memory.
    Virus Res. 2026 Mar 28:199718. doi: 10.1016/j.virusres.2026.199718.
    

    >> Share

    
    February 2026
15. LUO X, Liu H, Kuang H, Xie Y, et al
    Impacts of Delayed Influenza Vaccination on Clinical Outcomes in ICU-Admitted Patients with Influenza: A Retrospective Cohort Study.
    Virus Res. 2026 Feb 3:199700. doi: 10.1016/j.virusres.2026.199700.
    

    >> Share

    
    January 2026
16. NAZKI S, Reine J, Kailath R, Gilbert S, et al
    Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro.
    Virus Res. 2026;364:199691.
    

    >> Share

    
    
17. NGUYEN TTN, Tun MMN, Vu TBH, Nguyen TTT, et al
    Implications of Immune Responses to DENV, JEV, and ZIKV Infections for Cross-Reactivity and Considerations for Vaccine Evaluation.
    Virus Res. 2026 Jan 8:199689. doi: 10.1016/j.virusres.2026.199689.
    

    >> Share

    
    December 2025
18. KWAN E, Legione AR, Hartley CA, Devlin JM, et al
    Transcriptomic analysis of Crandell-Rees feline kidney cell infections with field and vaccine feline calicivirus strains.
    Virus Res. 2025 Dec 21:199681. doi: 10.1016/j.virusres.2025.199681.
    

    >> Share

    
    
19. IANKOV I, Ammayappan A, Viker K, Weisend C, et al
    Replication competent La Crosse virus pseudotyped VSV vector system as vaccine and serological diagnostic reagent.
    Virus Res. 2025 Dec 15:199676. doi: 10.1016/j.virusres.2025.199676.
    

    >> Share

    
    November 2025
20. KHAN A, Mohammad A, Alshabrmi FM, Alatawi EA, et al
    HMPV-TherResDB: Comprehensive Human Metapneumovirus (HMPV) Database for Sequence-Structure Annotations, Vaccine Resources, and Therapeutics Research.
    Virus Res. 2025 Nov 16:199665. doi: 10.1016/j.virusres.2025.199665.
    

    >> Share

    
    
21. CAO W, Li J, Yang F, Zhu Z, et al
    Comparative investigation into the immune efficiency of the single intradermal and intramuscular delivery of foot-and-mouth disease inactivated vaccine in swine.
    Virus Res. 2025 Nov 3:199656. doi: 10.1016/j.virusres.2025.199656.
    

    >> Share

    
    September 2025
22. VOKO Z, Turi G, Oroszi B, Belicza E, et al
    Association between COVID-19 vaccination and progression to severe outcomes in hospitalized COVID-19 patients in Hungary during the pre-Omicron era of the COVID-19 pandemic.
    Virus Res. 2025;361:199633.
    

    >> Share

    
    July 2025
23. MARTINEZ ES, Fuchs S, Szurmant H, Chen X, et al
    COVID-19 mRNA vaccine immune response to the addition of osteopathic manipulative treatment with lymphatic pumps: a randomized controlled trial.
    Virus Res. 2025 Jul 14:199607. doi: 10.1016/j.virusres.2025.199607.
    

    >> Share

    
    June 2025
24. YANG K
    Accelerating Vaccine Development: Plug-and-Play Platforms for Emerging Infectious Diseases.
    Virus Res. 2025 Jun 21:199601. doi: 10.1016/j.virusres.2025.199601.
    

    >> Share

    
    
25. LI H, Han J, Wang B, Han Z, et al
    Isolation and characterization of GI-19/L1148-like infectious bronchitis virus in China.
    Virus Res. 2025;356:199576.
    

    >> Share

    
    April 2025
26. MATHUR G, Mahilkar S, Sunil S
    Generation and characterization of infectious clones of chikungunya virus from an Indian strain as a resource towards chikungunya vaccine research.
    Virus Res. 2025;356:199571.
    

    >> Share

    
    March 2025
27. MYERS ML, Conlon MT, Gallagher JR, Woolfork DD, et al
    Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states.
    Virus Res. 2025 Mar 24:199563. doi: 10.1016/j.virusres.2025.199563.
    

    >> Share

    
    January 2025
28. RAHMAN MA, Zereen F, Rana ML, Hossain MG, et al
    Foot-and-mouth disease in Asia.
    Virus Res. 2025;351:199514.
    

    >> Share

    
    December 2024
29. GIRMA A
    Biology of human respiratory syncytial virus: Current perspectives in immune response and mechanisms against the virus.
    Virus Res. 2024;350:199483.
    

    >> Share

    
    
30. LU H, Shao J, Liu W, Gao S, et al
    Screening and identification of linear B-cell epitopes on structural proteins of African Swine Fever Virus.
    Virus Res. 2024;350:199465.
    

    >> Share

    
    October 2024
31. CHEN J, Cheng Z, Chen J, Qian L, et al
    Advances in human norovirus research: Vaccines, genotype distribution and antiviral strategies.
    Virus Res. 2024;350:199486.
    

    >> Share

    
    September 2024
32. CHEN Y, Tang Y, Zhang S, Tian Y, et al
    Evaluation of novel synthetic peptides of avian hepatitis E virus ORF2 as vaccine candidate in chickens.
    Virus Res. 2024 Sep 3:199459. doi: 10.1016/j.virusres.2024.199459.
    

    >> Share

    
    July 2024
33. ZHANG G, Peng Q, Liu S, Fan B, et al
    The glycosylation sites in RBD of spike protein attenuate the immunogenicity of PEDV AH2012/12.
    Virus Res. 2024;345:199381.
    

    >> Share

    
    June 2024
34. SPEDICATO M, Ronchi GF, Profeta F, Traini S, et al
    Efficacy of an inactivated EHDV-8 vaccine in preventing viraemia and clinical signs in experimentally infected cattle.
    Virus Res. 2024 Jun 17:199416. doi: 10.1016/j.virusres.2024.199416.
    

    >> Share

    
    
35. JALILVAND S, Latifi T, Kachooei A, Mirhoseinian M, et al
    Circulating rotavirus strains in children with acute gastroenteritis in Iran, 1986 to 2023 and their genetic/antigenic divergence compared to approved vaccines strains (Rotarix, RotaTeq, ROTAVAC, ROTASIIL) before mass vaccination: Clues for vaccinatio
    Virus Res. 2024;346:199411.
    

    >> Share

    
    May 2024
36. LIN X, Yang F, Yan S, Wu H, et al
    Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus.
    Virus Res. 2024;345:199402.
    

    >> Share

    
    April 2024
37. WANG Z, Sun W, Li D, Sun Y, et al
    A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice.
    Virus Res. 2024;345:199378.
    

    >> Share

    
    
38. AVIZINIENE A, Dalgediene I, Armalyte J, Petraityte-Burneikiene R, et al
    Immunogenicity of Novel vB_EcoS_NBD2 Bacteriophage-Originated Nanotubes as a Carrier for Peptide-Based Vaccines.
    Virus Res. 2024 Apr 11:199370. doi: 10.1016/j.virusres.2024.199370.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share